Recent News

• 06.12.2025 - Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
• 06.12.2025 - Rallybio Initiates Dosing in RLYB116 Phase 1 Confirmatory Pharmacokinetic/Pharmacodynamic Study
• 05.08.2025 - Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.08.2025 - Rallybio Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.07.2025 - The Citizens Life Sciences Conference
• 05.07.2025 - The Citizens Life Sciences Conference
• 04.29.2025 - Rallybio to Present at the 2025 Citizens JMP Life Sciences Conference

Recent Filings

• 05.16.2025 - 8-K Current report
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.09.2025 - S-8 Securities to be offered to employees in employee benefit plans